PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Hospital Cologne, Faculty of Medicine, University of Cologne, Kerpenerstr. 62, 50937, Cologne, Germany. Silke.vanKoningsbruggen@uk-koeln.de.\', \'European Cystic Fibrosis Society, Karup, Denmark.\', \'Queen\'s University Belfast, Belfast, UK.\', \'Erasmus MC-Sophia Children\'s Hospital, Rotterdam, The Netherlands.\', \'University Aix-Marseille, Marseille, France.\', \'Royal Brompton Hospital, London, UK.\', \'University Hospital Leuven, Leuven, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05457-5
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34454570
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34454570>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34454570>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all